UBS Group’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
UBS Group's EXEL Position: Q2 2026 in Review
UBS Group increased its Exelixis (EXEL) stake by 32% in Q2 2026, buying an estimated $37.7M and bringing the position to 3,167,890 shares worth $172M. The position accounts for 0.02% of the portfolio, ranked #752.
UBS Group first reported a position in EXEL in Q4 2014 and has held it in 47 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- UBS Group held 3,167,890 shares of Exelixis worth $172M as of Q2 2026.
- UBS Group bought 774,377 Exelixis shares in Q2 2026, an estimated $37.7M.
- Exelixis made up 0.02% of UBS Group's portfolio in Q2 2026, its #752 holding.
- UBS Group first reported a position in Exelixis in Q4 2014 and has held it in 47 quarters since.
- 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.